Login / Signup

Open trial of Bruton's tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceus.

Elizabeth C GoodaleStephen D WhitePetra BizikovaDori BorjessonDedee Frances MurrellAngelina BisconteMichelle FrancescoRonald J HillMohammad MasjedizadehPhilip NunnSteven G GourlayTyler J M JordanCarolyn B EmeryCatherine A Outerbridge
Published in: Veterinary dermatology (2020)
BTKi PRN1008 monotherapy may have some beneficial effects in some cases of cPF.
Keyphrases
  • combination therapy
  • clinical trial
  • study protocol
  • minimally invasive
  • open label
  • phase iii
  • phase ii
  • randomized controlled trial
  • genome editing